Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3'-, 4-, and 6'-galactosyllactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo1,2

Journal of Nutrition

Volumn 146, Issue 2, 2016, Pages 358-367

  Newburg, David S ^a   Ko, Jae Sung ^b   Leone, Serena ^a   Nanthakumar, N Nanda ^c  

^a BOSTON COLLEGE   (United States)

^b Seoul National University Children's Hospital   (South Korea)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Colostrum; Enteric infection; Galactosyllactose; Human intestinal epithelium; Human milk oligosaccharides; Mucosal immune response

Indexed keywords

3' GALACTOSYLLACTOSE; 4 GALACTOSYLLACTOSE; 6' GALACTOSYLLACTOSE; GALACTOSE OLIGOSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTOSE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGOSACCHARIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3'-GALACTOSYLLACTOSE; ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE; TRISACCHARIDE;

ARTICLE; BREAST MILK; COLOSTRUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; H4 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINAL TISSUE; LACTATION; LISTERIA; NCM 460 CELL LINE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA; SALMONELLOSIS; SIGNAL TRANSDUCTION; T84 CELL LINE; ANIMAL; CELL LINE; CHEMISTRY; COLON; DRUG EFFECTS; FEMALE; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PREGNANCY; SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; COLON; COLOSTRUM; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LACTATION; LACTOSE; LISTERIA; MICE; MILK, HUMAN; OLIGOSACCHARIDES; PREGNANCY; SALMONELLA; SALMONELLA INFECTIONS; SIGNAL TRANSDUCTION; TRISACCHARIDES;

EID: 84959303967     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.220749     Document Type: Article

References (49)

1. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 2013;60:49-74.
2. Nanthakumar NN. The regulation of functional development of the small intestine. In: Delvin E, Lentze MJ, editors. Gastrointestinal functions. Nestlé Nutrition Workshop Series. Vol. 46. Vevey, Nestlé/Philadelphia: Lippincott Williams & Wilkins; 2001. p. 39-58.
3. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007;61:2-8.
4. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37-58.
5. Jantscher-Krenn E, Zherebtsov M, Nissan C, Goth K, Guner YS, Naidu N, Choudhury B, Grishin AV, Ford HR, Bode L. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 2012;61:1417-25.
6. Newburg DS. Glycobiology of human milk. Biochemistry (Mosc) 2013;78:771-85.
7. Nanthakumar NN, Meng D, Newburg DS. Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis. Glycobiology 2013;23:1131-41.
8. Newburg DS, Grave G. Recent advances in human milk glycobiology. Pediatr Res 2014;75:675-9.
9. He Y, Liu S, Leone S, Newburg DS. Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol 2014;7:1326-39.
10. Yu ZT, Chen CC, Newburg DS. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 2013;23:1281-92.
11. Garrido D, Baril D, Mills DA. A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract. Adv Nutr 2012;3:415S-21S.
12. György P, Jeanloz RW, von Nicolai H, Zilliken F. Undialyzable growth factors for Lactobacillus bifidus var. pennsylvanicus. Protective effect of sialic acid bound to glycoproteins and oligosaccharides against bacterial degradation. Eur J Biochem 1974;43:29-33.
13. McCartney AL, Gibson GR. The normal microbiota of the human gastrointestinal tract: history of analysis, succession, and dietary influences. In: Ouwehand AC, Vaughan EE, editors. Gastrointestinal microbiology. New York: CRC press; 2013. p. 51-74.
14. Tzortzis G, Vulevic J. Galacto-oligosaccharide prebiotics. In: Charalampopoulos D, Rastall RA, editors. Prebiotics and probiotics science and technology. New York: Springer; 2009. p. 207-244.
15. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000;97:6043-8.
16. Nanthakumar NN, Young C, Ko JS, Meng D, Chen J, Buie T, Walker WA. Glucocorticoid responsiveness in the developing human intestine: A possible role in the prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G85-92.
17. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, Llanos A, Claud EC, WalkerWA. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 2011;6:e17776.
18. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 2013;5:661-74.
19. Thomas CJ, Schroder K. Pattern recognition receptor function in neutrophils. Trends Immunol 2013;34:317-28.
20. Schenten D, Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv Immunol 2011;109:87-124.
21. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
22. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519-31.
23. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourié B, Brouns F, Bornet FR. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80:1658-64.
24. Bouhnik Y, Flourié B, D'Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud JC. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997;127:444-8.
25. Gopal KP, Prosad J, Gill HS. Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galactooligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 2003;23:1313-28.
26. Hopkins MJ, Macfarlane GT. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 2003;69:1920-7.
27. Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L, Weyer U, Dugdale AH, Cooley WA, Carter B, Jones G, et al. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 2009;58:37-48.
28. Holma R, Juvonen P, Asmawi MZ, Vapaatalo H, Korpela R. Galactooligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol 2002;37:1042-7.
29. Chaturvedi P, Warren CD, Ruiz-Palacios GM, Pickering LK, Newburg DS. Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives. Anal Biochem 1997;251:89-97.
30. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, Pickering LK, Newburg DS. Fucosylated human milk oligosaccharides vary among individuals over the course of lactation. Glycobiology 2001;11:365-72.
31. Bao Y, Chen C, Newburg DS. Quantification of neutral human milk oligosaccharides by graphitic carbon high-performance liquid chromatography with tandem mass spectrometry. Anal Biochem 2013;433:28-35.
32. Cherayil BJ, McCormick BA, Bosley J. Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2. Infect Immun 2000;68:5567-74.
33. Criss AK, Casanova JE. Coordinate regulation of Salmonella enterica serovar Typhimurium invasion of epithelial cells by the Arp2/3 complex and Rho GTPases. Infect Immun 2003;71:2885-91.
34. Sanderson IR, Ezzell RM, Kedinger M, Erlanger M, Xu ZX, Pringault E, Leon-Robine S, Louvard D, Walker WA. Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc Natl Acad Sci USA 1996;93:7717-22.
35. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004;101:7404-8.
36. Rautava S, Lu L, Nanthakumar NN, Dubert-Ferrandon A, Walker WA. TGF-b2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NFkB pathway. J Pediatr Gastroenterol Nutr 2012;54:630-8.
37. Garrison AF, Abt FH. Abt-Garrison history of pediatrics. Philadelphia: WB Saunders; 1965, p. 316.
38. Ehrlich P, Hubner W. Uber die Ubertragung von Immunitat durch Milch. [On the transfer of immunity by milk.] Deutsch Med Wochenschr 1892;18:393.
39. Tissier H. Repartition des microbes dans l'intestin du nourisson. [Distribution of microbes in the gut of the infant.] Ann Inst Pasteur (Paris) 1905;19:109-13 (in French).
40. Chowers Y, Lider O, Schor H, Barshack I, Tal R, Ariel A, Bar-Meir S, Cohen IR, Cahalon L. Disaccharides derived from heparin or heparan sulfate regulate IL-8 and IL-1 beta secretion by intestinal epithelial cells. Gastroenterology 2001;120:449-59.
41. Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, Williams IR, Koval M, Peatman E, Campbell JA, et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 2007;204:3067-76.
42. Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si-Tahar M, Madara JL. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 2001;107:861-9.
43. Gnoth MJ, RudloffS, Kunz C, Kinne RK. Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem 2001;276:34363-70.
44. Duerr CU, Hornef MW. The mammalian intestinal epithelium as integral player in the establishment and maintenance of hostmicrobial homeostasis. Semin Immunol 2012;24:25-35.
45. Grishin A, Papillon S, Bell B, Wang J, Ford HR. The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2013;22:69-75.
46. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994;180:15-23.
47. Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K, Sasakawa C, Suzuki T, Nochi T, Yokota Y, Rennert PD, et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004;101:6110-5.
48. Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, Hemmi H, Knoop KA, Kumar N, Sato M, et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol 2012;13:729-36.
49. Engelbrecht F, Chun S-K, Ochs C, Hess J, Lottspeich F, Goebel W, Sokolovic Z. A new PrfA-regulated gene of Listeria monocytogenes encoding a small, secreted protein which belongs to the family of internalins. Mol Microbiol 1996;21:823-37.